US Stock MarketDetailed Quotes

IPSC Century Therapeutics

Watchlist
  • 1.220
  • -0.040-3.17%
Close Nov 15 16:00 ET
  • 1.220
  • 0.0000.00%
Post 20:01 ET
103.74MMarket Cap-666P/E (TTM)

Century Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Total revenue
434.46%791K
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
-93.35%148K
-92.91%99K
62.57%1.72M
5.2M
521K
Operating revenue
434.46%791K
678.79%771K
-50.29%855K
-57.01%2.24M
-48.56%268K
-93.35%148K
-92.91%99K
62.57%1.72M
--5.2M
--521K
Cost of revenue
Gross profit
Operating expense
11.98%35.58M
14.76%35.53M
-4.84%32.16M
-1.25%127.42M
-8.70%30.89M
-6.44%31.77M
-5.47%30.96M
18.62%33.8M
35.99%129.03M
20.93%33.83M
Selling and administrative expenses
-7.06%8.35M
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
11.43%8.99M
-0.29%8.23M
21.98%8.9M
65.62%31.86M
33.43%8.24M
-General and administrative expense
-7.06%8.35M
0.94%8.31M
-1.79%8.74M
8.94%34.71M
4.21%8.59M
11.43%8.99M
-0.29%8.23M
21.98%8.9M
65.62%31.86M
33.43%8.24M
Research and development costs
19.48%27.23M
19.77%27.22M
-5.94%23.42M
-4.59%92.71M
-12.86%22.3M
-12.01%22.79M
-7.21%22.73M
17.47%24.9M
28.45%97.17M
17.38%25.59M
Operating profit
-10.00%-34.79M
-12.63%-34.76M
2.41%-31.31M
-1.09%-125.18M
8.07%-30.62M
0.35%-31.63M
1.58%-30.86M
-16.93%-32.08M
-30.51%-123.83M
-19.06%-33.31M
Net non-operating interest income expense
-5.19%3.31M
22.59%3.58M
45.88%3.24M
305.92%12.14M
114.42%3.51M
235.84%3.49M
677.13%2.92M
3,737.70%2.22M
334.51%2.99M
609.97%1.64M
Non-operating interest income
-5.19%3.31M
17.14%3.58M
23.41%3.24M
186.81%12.68M
71.22%3.51M
147.06%3.49M
333.14%3.06M
936.76%2.62M
--4.42M
--2.05M
Non-operating interest expense
--0
--0
--0
-55.00%540K
--0
--0
-46.46%136K
46.22%348K
23.84%1.2M
69.26%413K
Total other finance cost
----
----
----
----
----
----
----
-26.32%56K
-24.84%230K
--0
Other net income (expense)
106.27%250K
99.73%-12K
105.67%11K
-117.48%-21.75M
-69,363.16%-13.16M
-16,516.67%-3.99M
-88,220.00%-4.41M
98.06%-194K
-2,752.52%-10M
-86.71%19K
Special income (charges)
--0
--0
----
-113.65%-21.37M
---13.15M
---4M
---4.22M
----
---10M
--0
-Less:Impairment of capital assets
--0
--0
----
--16.37M
--12.15M
--0
--4.22M
----
--0
--0
-Less:Other special charges
----
----
----
-50.00%5M
--1M
--4M
----
----
--10M
--0
Other non- operating income (expenses)
1,983.33%250K
93.55%-12K
105.67%11K
---383K
---15K
150.00%12K
-3,820.00%-186K
---194K
----
----
Income before tax
2.78%-31.23M
3.57%-31.19M
6.64%-28.06M
-3.02%-134.79M
-27.23%-40.27M
-4.57%-32.13M
-4.43%-32.34M
19.84%-30.06M
-36.60%-130.84M
-12.43%-31.65M
Income tax
-101.35%-8K
-97.68%22K
-99.92%1K
1,967.03%1.88M
-2,815.63%-869K
2,268.00%592K
5,177.78%950K
7,450.00%1.21M
111.63%91K
32K
Net income
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Net income continuous Operations
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Minority interest income
Net income attributable to the parent company
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders
4.57%-31.23M
6.26%-31.21M
10.24%-28.06M
-4.38%-136.67M
-24.35%-39.4M
-6.41%-32.72M
-7.43%-33.29M
16.66%-31.26M
-36.64%-130.93M
-12.37%-31.68M
Basic earnings per share
32.73%-0.37
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
-3.77%-0.55
-3.70%-0.56
19.70%-0.53
23.31%-2.27
-7.30%-0.55
Diluted earnings per share
32.73%-0.37
32.14%-0.38
15.09%-0.45
-1.32%-2.3
-18.18%-0.65
-3.77%-0.55
-3.70%-0.56
19.70%-0.53
23.31%-2.27
-7.30%-0.55
Dividend per share
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Total revenue 434.46%791K678.79%771K-50.29%855K-57.01%2.24M-48.56%268K-93.35%148K-92.91%99K62.57%1.72M5.2M521K
Operating revenue 434.46%791K678.79%771K-50.29%855K-57.01%2.24M-48.56%268K-93.35%148K-92.91%99K62.57%1.72M--5.2M--521K
Cost of revenue
Gross profit
Operating expense 11.98%35.58M14.76%35.53M-4.84%32.16M-1.25%127.42M-8.70%30.89M-6.44%31.77M-5.47%30.96M18.62%33.8M35.99%129.03M20.93%33.83M
Selling and administrative expenses -7.06%8.35M0.94%8.31M-1.79%8.74M8.94%34.71M4.21%8.59M11.43%8.99M-0.29%8.23M21.98%8.9M65.62%31.86M33.43%8.24M
-General and administrative expense -7.06%8.35M0.94%8.31M-1.79%8.74M8.94%34.71M4.21%8.59M11.43%8.99M-0.29%8.23M21.98%8.9M65.62%31.86M33.43%8.24M
Research and development costs 19.48%27.23M19.77%27.22M-5.94%23.42M-4.59%92.71M-12.86%22.3M-12.01%22.79M-7.21%22.73M17.47%24.9M28.45%97.17M17.38%25.59M
Operating profit -10.00%-34.79M-12.63%-34.76M2.41%-31.31M-1.09%-125.18M8.07%-30.62M0.35%-31.63M1.58%-30.86M-16.93%-32.08M-30.51%-123.83M-19.06%-33.31M
Net non-operating interest income expense -5.19%3.31M22.59%3.58M45.88%3.24M305.92%12.14M114.42%3.51M235.84%3.49M677.13%2.92M3,737.70%2.22M334.51%2.99M609.97%1.64M
Non-operating interest income -5.19%3.31M17.14%3.58M23.41%3.24M186.81%12.68M71.22%3.51M147.06%3.49M333.14%3.06M936.76%2.62M--4.42M--2.05M
Non-operating interest expense --0--0--0-55.00%540K--0--0-46.46%136K46.22%348K23.84%1.2M69.26%413K
Total other finance cost -----------------------------26.32%56K-24.84%230K--0
Other net income (expense) 106.27%250K99.73%-12K105.67%11K-117.48%-21.75M-69,363.16%-13.16M-16,516.67%-3.99M-88,220.00%-4.41M98.06%-194K-2,752.52%-10M-86.71%19K
Special income (charges) --0--0-----113.65%-21.37M---13.15M---4M---4.22M-------10M--0
-Less:Impairment of capital assets --0--0------16.37M--12.15M--0--4.22M------0--0
-Less:Other special charges -------------50.00%5M--1M--4M----------10M--0
Other non- operating income (expenses) 1,983.33%250K93.55%-12K105.67%11K---383K---15K150.00%12K-3,820.00%-186K---194K--------
Income before tax 2.78%-31.23M3.57%-31.19M6.64%-28.06M-3.02%-134.79M-27.23%-40.27M-4.57%-32.13M-4.43%-32.34M19.84%-30.06M-36.60%-130.84M-12.43%-31.65M
Income tax -101.35%-8K-97.68%22K-99.92%1K1,967.03%1.88M-2,815.63%-869K2,268.00%592K5,177.78%950K7,450.00%1.21M111.63%91K32K
Net income 4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M-36.64%-130.93M-12.37%-31.68M
Net income continuous Operations 4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M-36.64%-130.93M-12.37%-31.68M
Minority interest income
Net income attributable to the parent company 4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M-36.64%-130.93M-12.37%-31.68M
Preferred stock dividends
Other preferred stock dividends
Net income attributable to common stockholders 4.57%-31.23M6.26%-31.21M10.24%-28.06M-4.38%-136.67M-24.35%-39.4M-6.41%-32.72M-7.43%-33.29M16.66%-31.26M-36.64%-130.93M-12.37%-31.68M
Basic earnings per share 32.73%-0.3732.14%-0.3815.09%-0.45-1.32%-2.3-18.18%-0.65-3.77%-0.55-3.70%-0.5619.70%-0.5323.31%-2.27-7.30%-0.55
Diluted earnings per share 32.73%-0.3732.14%-0.3815.09%-0.45-1.32%-2.3-18.18%-0.65-3.77%-0.55-3.70%-0.5619.70%-0.5323.31%-2.27-7.30%-0.55
Dividend per share
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------

Analysis

Analyst Rating

No Data

Price Target

No Data

Heat List
US
Overall
Symbol
Latest Price
% Chg

No Data